Search
The results of your search are listed below. To view the details of a trial or study, click on the "SEE DETAILS" button. Or start a new search.
Searched for: cord blood. 8 results shown below.
Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Complete title: Allogeneic Hematopoietic Cell Transplantation for Patients with Nonmalignant Inherited Disorders Using a Treosulfan Based Preparative Regimen
Principal Investigator: Lauri Burroughs, MD
Study Number: 2256.00
Phase: II
Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants (LVXSCID-ND)
Complete title: A Pilot Feasibility Study of Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants Using a Self-Inactivating Lentiviral Vector to Transduce Autologous CD34+ Hematopoietic Cells
Principal Investigator: Aleksandra Petrovic
Study Number: 9356
Phase: I/II
Cord Blood Transplant With OTS for the Treatment of HIV Positive Hematologic Cancers
Complete title: Infusion of off-the-shelf ex vivo Expanded Cryopreserved Progenitor Cells to Facilitate the Engraftment of a Single CCR532 Homozygous or Heterozygous Cord Blood Unit in Patients with HIV and Hematological Malignancies
Principal Investigator: Filippo Milano
Study Number: RG1004070
Phase: II
Itacitinib for Low Risk GVHD
Complete title: Itacitinib Monotherapy for Low Risk Graft-vs-Host Disease
Principal Investigator: Marco Mielcarek, MD
Study Number: RG1006012
Phase: II
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease
Complete title: Transplantation of Umbilical Cord Blood for Patients with Hematological Diseases with Cyclophosphamide/Fludarabine/Total Body Irradiation or Cyclophosphamide/Fludarabine/Thiotepa/Total Body Irradiation Myeloablative Preparative Regimen
Principal Investigator: Ann Dahlberg
Study Number: 2010.00
Phase: II
Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy
Complete title: High-Dose Immunosuppressive Therapy Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) + Thymoglobulin Followed by Syngeneic or Autologous Hematopoietic Cell Transplantation for Patients with Autoimmune Neurologic Diseases
Principal Investigator: George Georges, MD
Study Number: 2260.00
Phase: II
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Complete title: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications
Principal Investigator: Ann Dahlberg
Study Number: 2531.00
Phase: N/A
UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia
Complete title: A Phase II Open-label Study of UM171 Expanded Cord Blood Transplantation in Patients with High and Very High Risk Acute Leukemia/Myelodysplasia
Principal Investigator: Filippo Milano
Study Number: RG1004028
Phase: II